Filter
696
Filtered Results: 696
Text search:
pipeline
Featured
Recommendations
75
New Publications
184
Language
Document type
No document type
310
Studies & Reports
140
Guidelines
93
Strategic & Response Plan
54
Manuals
38
Situation Updates
24
Fact sheets
19
Resource Platforms
6
Infographics
4
Videos
3
Training Material
2
Online Courses
2
Brochures
1
Countries / Regions
Global
33
South Sudan
19
India
19
Syria
18
Kenya
17
Ethiopia
17
South Africa
16
Ukraine
14
Nigeria
14
Africa
14
Uganda
14
Mozambique
13
East and Southern Africa
10
Liberia
10
Myanmar / Burma
10
Sierra Leone
9
Rwanda
9
Nepal
8
Haiti
8
Latin America and the Carribbean
8
Zambia
8
Malawi
7
Tanzania
7
Bangladesh
7
Yemen
7
West and Central Africa
6
Asia
5
Botswana
5
China
4
USA
4
Congo, Democratic Republic of
4
Turkey
3
Burundi
3
Philippines
3
Guinea
3
Jordan
3
South–East Asia Region
3
Western and Central Europe
3
Eastern Europe
3
Russia
3
Namibia
3
Sudan
3
Central African Republic
3
Indonesia
3
Ghana
2
Benin
2
Albania
2
Senegal
2
Burkina Faso
2
Zimbabwe
2
Western Pacific Region
2
Southern Africa
2
Brazil
2
Moldova
2
Somalia
2
Colombia
1
Thailand
1
Serbia
1
Cameroon
1
Singapore
1
Laos
1
Afghanistan
1
Qatar
1
Italy
1
Venezuela
1
Hungary
1
Germany
1
Saudi Arabia
1
Middle East and North Africa
1
North America
1
Portugal
1
Belarus
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Vietnam
1
Sri Lanka
1
Egypt
1
Romania
1
Poland
1
Mali
1
Angola
1
Bhutan
1
Iraq
1
Ecuador
1
Eswatini/ Swaziland
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
226
Clinical Guidelines
50
Key Resources
41
Pharmacy & Technologies
26
Public Health
23
Women & Child Health
15
Capacity Building
4
Annual Report MEDBOX
1
Toolboxes
COVID-19
87
AMR
73
TB
55
Conflict
53
HIV
51
Natural Hazards
29
NTDs
25
Planetary Health
24
Pharmacy
13
Rapid Response
12
Ebola
12
Mental Health
11
Specific Hazards
11
Health Financing Toolbox
11
Global Health Education
7
Caregiver
5
Disability
4
Refugee
3
Cholera
3
Zika
3
Typhoon
2
Social Ethics
1
Polio
1
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
htb supplement: 2018 Vol 19:(1)
New drugs in development
July 2018
www.i-Base.info
This tracker, developed by the Vaccine Centre at the London School of Hygiene & Tropical Medicine, will follow COVID-19 vaccine candidates as they progress through the development pipeline. We will update it weekly. An overview of the different vaccine types as well as the phases of clinical develo...
Many in-house and commercial assays that detect the COVID-19 virus have been developed or are currently under development. Many of these molecular assays are currently being validated in partner laboratories. An overview of assays that have applied to FIND for participation in their assay assessment...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...
The pre-clinical pipeline shows more innovation and diversity, with 252 agents being developed to treat WHO priority pathogens.
However, these products are in the very early stages of development and still need to be proven effective and safe. The optimistic scenario, the report indicates, is for...
29 April 2022
What are the new vaccines in the pipeline? What are the challenges to turning vaccines into vaccination ? What timelines can we expect for future vaccines? WHO’s Dr Katherine O’Brien explains in Science in 5.
How do vaccines work to protect us? What are the vaccine technologies in the pipeline and how do we ensure safe vaccines? Dr Katherine O’ Brien explains in Science in 5 !
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent...
Overuse and misuse of antibiotics in animals and humans is contributing to the rising threat of antibiotic resistance. Some types of bacteria that cause serious infections in humans have already developed resistance to most or all of the available treatments, and there are very...
COVID-19 vaccine tracker and landscape
recommended
The COVID-19 vaccine tracker and landscape compiles detailed information of each COVID-19 vaccine candidate in development by closely monitoring their progress through the pipeline.
The COVID-19 vaccine tracker:
Provides summary tables of COVID-19 vaccine candidates in both clinical and pre-...
Antimicrobial resistance (AMR) as a serious public health threat was globally acknowledged by WHO in 2015, through the launch of the Global Action Plan (GAP). With a limited number of new antibiotics in the developmental pipeline, many countries are in the process of establishing strategies for anti...
Accessed on 22.04.2023
To target helminth elimination, a new consortium of research institutes, universities, not-for-profit organizations, and pharmaceutical companies have joined forces and expertise to establish a research and development pipeline for the development of anthelminthics targeti...
OpenWHO is an interactive, web-based, knowledge-transfer platform offering free online courses to improve the response to health emergencies. COVID-19 resources are available in the official WHO languages and in additional national languages .The OpenWHO team is continuing to work with WHO ...
August 2020, The Africa Joint Continental Strategy for COVID-19 is underpinned by the need to limit transmission, prevent deaths and reduce associated harms. Participation by African nations in clinical trials is an essential step to ensure that sufficient data is generated on the safety and efficac...
COVID-19 vaccine market dashboard
recommended
An interactive tool for partners, manufacturers, and countries to follow the developments of the COVID-19 vaccine market with up-to-date information.
As the designated COVAX procurement coordinator and procurement agent, UNICEF has launched the COVID-19 Vaccine Market Dashboard – an interactive ...
The protozoan parasite Trypanosoma cruzi causes Chagas disease, an important public health problem throughout Latin America. Current therapeutic options are characterised by limited efficacy, long treatment regimens and frequent toxic side-effects. Advances in this area have been compromised by gaps...
The development of this target product profile (TPP) was led by the WHO Department of Control of Neglected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG) was form...
